The efficacy of aspirin to inhibit platelet aggregation in patients hospitalised with a severe infection: a multicentre, open‑label, randomised controlled trial
type: Dataset
description: We investigated whether hyperaggregation occurs during infection, and whether aspirin inhibits this. Patients hospitalised due to acute infection were randomised to receive 10 days of aspirin treatment or no intervention. Our outcome measures were PFA-Closure Time, serum thromboxane and plasma thromboxane.
keyword: ASPIRIN
keyword: Female
keyword: Hospital
keyword: Longitudinal
keyword: Male
keyword: Not available
keyword: Other
keyword: Physiological Biochemical measurements
keyword: Pneumonia due to staphylococcus aureus
keyword: Sample collection
issued: 2018-01-11T00:00:00+00:00
modified: 2026-08-08T02:28:20.364022
language: en
theme: HEAL
access rights: RESTRICTED
provenance: ProvenanceStatement
is referenced by: s10238-023-01101-5
is referenced by: https://pubmed.ncbi.nlm.nih.gov/37294478/
applicable legislation: oj
qualified attribution: Attribution
  agent: Dutch Cardiovascular Alliance (DCVA)
contact point: Kind
  fn: DCVA
  has URL: ']
publisher: Dutch Cardiovascular Alliance (DCVA)
creator: Dutch Cardiovascular Alliance (DCVA)
temporal: PeriodOfTime
  start date: 2018-01-11T00:00:00+00:00
  end date: 2020-12-10T00:00:00+00:00
spatial: NLD
population coverage: collection type: Hospital,Longitudinal,Sample collection,Other | disease: Pneumonia due to staphylococcus aureus | data categories: Physiological/Biochemical measurements | materials: Not available | omics: Not available | imaging: N | sex: Female,Male
min typical age: 23
max typical age: 93
number of unique individuals: 54